Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: Consensus opinion of the blood and marrow transplant clinical trials network (BMT CTN)

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 1, 2015, Pages 4-7

  Howard, C Alan ^a   Fernandez Vina, Marcelo A ^b   Appelbaum, Frederick R ^c   Confer, Dennis L ^a,d   Devine, Steven M ^e   Horowitz, Mary M ^f   Mendizabal, Adam ^g   Laport, Ginna G ^b   Pasquini, Marcelo C ^f   Spellman, Stephen R ^a  

^a CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NATIONAL MARROW DONOR PROGRAM   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g EMMES CORPORATION   (United States)

Author keywords

Allogeneic transplantations; Cord blood donor; Recipient; Related donor; Unrelated donor

Indexed keywords

HLA ANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONSENSUS; DONOR SELECTION; EVIDENCE BASED MEDICINE; GRAFT RECIPIENT; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MULTICENTER STUDY (TOPIC); ORGAN DONOR; OVERALL SURVIVAL; PATIENT SELECTION; PRACTICE GUIDELINE; RELATIVE; SIBLING; STANDARDIZATION; UMBILICAL CORD BLOOD; UNRELATED DONORS; ALLOTRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; HISTOCOMPATIBILITY TEST; STANDARDS;

BONE MARROW TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; CONSENSUS; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84924246712     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.09.017     Document Type: Article

References (28)

1. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2013. Available at: http://www.cibmtr.org.
2. Ballen K.K., King R.J., Chitphakdithai P., et al. The National Marrow Donor Program 20 years of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008, 14:2-7.
3. Luznik L., O'Donnell P.V., Symons H.J., et al. HLA-Haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008, 14:641-650.
4. Shaw P.J., Kan F., Woo Ahn K., Spellman S.R., et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood 2010, 116:4007-4015.
5. Valcárcel D., Sierra J., Wang T., et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplant 2011, 17:640-648.
6. Ciurea S.O., de Lima M., Cano P., et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009, 88:1019-1024.
7. Gragert L., Eapen M., Williams E., et al. HLA match likelihoods for patients seeking unrelated donor grafts in the U.S. registry. NEngl J Med 2014, 371:339-348.
8. Lee S.J., Klein J., Haagenson M., et al. High resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
9. Woolfrey A., Klein J.P., Haagenson M., et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:885-892.
10. Spellman S.R., Eapen M., Logan B.R., et al. Aperspective on the selection of unrelated donors and cord blood units for transplantation. Blood 2012, 120:259-265.
11. Marsh S.G., Albert E.D., Bodmer W.F., et al. An update to HLA nomenclature, 2010. Bone Marrow Transplant 2010, 45:846-848.
12. Xiao Y., Lazaro A.M., Masaberg C., et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens 2009, 73:595-598.
13. Pasi A., Crocchiolo R., Bontempelli M., et al. The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT. Bone Marrow Transplant 2011, 46:916-922.
14. Fernández-Viña M.A., Klein J.P., Haagenson M., et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood 2013, 121:4603-4610.
15. Crocchiolo R., Zino E., Vago L., et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114:1437-1444.
16. Fleischhauer K., Shaw B.E., Gooley T., et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012, 13:366-374.
17. Pidala J., Lee S.J., Ahn K.W., et al. Non-permissive -DPB1 mismatch among otherwise HLA-matched donor-recipient pairs results in increased overall mortality after unrelated allogeneic hematopoietic cell transplantation: A CIBMTR/NMDP Analysis. Blood 2014, 123:1270-1278.
18. Spellman S., Bray R., Rosen-Bronson S., et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010, 115:2704-2708.
19. Ciurea S.O., Thall P.F., Wang X., et al. Donor specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 2011, 118:5957-5964.
20. Fernandez-Viña M.A., Wang T., Lee S.J., et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood 2014, 123:1270-1278.
21. Hurley C.K., Woolfrey A., Wang T., et al. The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood 2013, 121:4800-4806.
22. Kollman C., Klein J.P., Spellman S., et al. The effect of donor characteristicson graft vs. host disease (GVHD) and survival after unrelated donor transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2013, 19(2):S146-147.
23. Ballen K.K., Koreth J., Chen Y.B., et al. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood 2012, 119:1972-1980.
24. Eapen M., Klein J.P., Ruggeri A., et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014, 123:133-140.
25. Takanashi M., Atsuta Y., Fujiwara K., et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010, 116:2839-2846.
26. Cutler C., Kim H.T., Sun L., et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood 2011, 118:6691-6697.
27. Rocha V., Spellman S., Zhang M.J., et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012, 18:1890-1896.
28. van Rood J.J., Stevens C.E., Smits J., et al. Re-exposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci U S A 2009, 106:19952-19957.